FDA Recalls Tiagabine Hydrochloride Tablets Due to Impurity Specification Failures
Sun Pharmaceutical is recalling Tiagabine Hydrochloride Tablets (2 mg) due to out-of-specification impurities detected during testing. The recall affects lot HAC3339A distributed nationwide.
- Product
- TIAGABINE HYDROCHLORIDE — TIAGABINE HYDROCHLORIDE (TIAGABINE HYDROCHLORIDE)
- Category
- Drug
- Distribution
- Distributed nationwide